title: Role of JNK in a Trp53-dependent mouse model of breast cancer.
abstract: The cJun NH2-terminal kinase (JNK) signal transduction pathway has been implicated in mammary carcinogenesis. To test the role of JNK, we examined the effect of ablation of the Jnk1 and Jnk2 genes in a Trp53-dependent model of breast cancer using BALB/c mice. We detected no defects in mammary gland development in virgin mice or during lactation and involution in control studies of Jnk1(-/-) and Jnk2(-/-) mice. In a Trp53(-/+) genetic background, mammary carcinomas were detected in 43% of control mice, 70% of Jnk1(-/-) mice, and 53% of Jnk2(-/-) mice. These data indicate that JNK1 and JNK2 are not essential for mammary carcinoma development in the Trp53(-/+) BALB/c model of breast cancer. In contrast, this analysis suggests that JNK may partially contribute to tumor suppression. This conclusion is consistent with the finding that tumor-free survival of JNK-deficient Trp53(-/+) mice was significantly reduced compared with control Trp53(-/+) mice. We conclude that JNK1 and JNK2 can act as suppressors of mammary tumor development.
authors.affiliation: Howard Hughes Medical Institute, Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
authors.forename: Cristina
authors.initials: C
authors.lastname: Cellurale
authors.forename: Claire R
authors.initials: CR
authors.lastname: Weston
authors.forename: Judith
authors.initials: J
authors.lastname: Reilly
authors.forename: David S
authors.initials: DS
authors.lastname: Garlick
authors.forename: D Joseph
authors.initials: DJ
authors.lastname: Jerry
authors.forename: Hayla K
authors.initials: HK
authors.lastname: Sluss
authors.forename: Roger J
authors.initials: RJ
authors.lastname: Davis
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D005260:Female; D008321:Mammary Glands, Animal / Q000201:enzymology / Q000254:growth & development; D051379:Mice; D008807:Mice, Inbred BALB C; D048055:Mitogen-Activated Protein Kinase 8 / Q000172:deficiency / Q000378:metabolism*; D048056:Mitogen-Activated Protein Kinase 9 / Q000172:deficiency / Q000378:metabolism*; D016019:Survival Analysis; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency / Q000378:metabolism*
chemical_list: D016159:Tumor Suppressor Protein p53; D048056:Mitogen-Activated Protein Kinase 9; D048055:Mitogen-Activated Protein Kinase 8
references.citation: Neuron. 1999 Apr;22(4):667-76
references.pmid: 10230788
references.citation: J Biol Chem. 2000 Aug 11;275(32):24767-75
references.pmid: 10825181
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15759-64
references.pmid: 17893331
references.citation: Oncogene. 2007 May 14;26(22):3172-84
references.pmid: 17496914
references.citation: Clin Cancer Res. 2003 Jan;9(1):391-401
references.pmid: 12538493
references.citation: Mol Cell Biol. 1999 Mar;19(3):1938-49
references.pmid: 10022881
references.citation: Mol Cell. 2006 Sep 15;23(6):899-911
references.pmid: 16973441
references.citation: Oncogene. 1998 Nov 5;17(18):2305-12
references.pmid: 9811461
references.citation: Cancer Res. 2004 Aug 1;64(15):5140-7
references.pmid: 15289317
references.citation: J Mammary Gland Biol Neoplasia. 2001 Oct;6(4):441-51
references.pmid: 12013533
references.citation: Nature. 1992 Mar 19;356(6366):215-21
references.pmid: 1552940
references.citation: Cancer Res. 1998 Jun 1;58(11):2339-42
references.pmid: 9622070
references.citation: Curr Opin Cell Biol. 2007 Apr;19(2):142-9
references.pmid: 17303404
references.citation: Oncogene. 2001 Aug 2;20(34):4621-8
references.pmid: 11498785
references.citation: Cell. 2009 Jan 23;136(2):249-60
references.pmid: 19167327
references.citation: Nat Genet. 2002 Sep;32(1):201-5
references.pmid: 12161751
references.citation: Science. 2000 May 5;288(5467):870-4
references.pmid: 10797012
references.citation: Cancer Res. 2006 Oct 15;66(20):10024-31
references.pmid: 17047065
references.citation: Hum Mutat. 2002 Jan;19(1):81
references.pmid: 11754110
references.citation: PLoS One. 2010 May 03;5(5):e10443
references.pmid: 20454618
references.citation: Cancer Res. 2001 May 15;61(10):3908-12
references.pmid: 11358804
references.citation: Mol Cell. 2004 Nov 19;16(4):521-35
references.pmid: 15546613
references.citation: Immunity. 1998 Oct;9(4):575-85
references.pmid: 9806643
references.citation: Cancer Res. 1997 Oct 1;57(19):4177-82
references.pmid: 9331070
references.citation: J Clin Invest. 2008 Dec;118(12):3943-53
references.pmid: 19033664
references.citation: Cell. 2000 Oct 13;103(2):239-52
references.pmid: 11057897
references.citation: Am J Pathol. 2000 Dec;157(6):2151-9
references.pmid: 11106587
references.citation: Science. 1998 Dec 11;282(5396):2092-5
references.pmid: 9851932
references.citation: Science. 2007 Nov 16;318(5853):1108-13
references.pmid: 17932254
references.citation: Curr Biol. 1994 Jan 1;4(1):1-7
references.pmid: 7922305